Retroperitoneal lymph node dissection: reassessment of modified templates

Area of Science:

• Urology
• Surgical Oncology
• Medical Oncology

Background:

• The retroperitoneum is the primary site for metastasis in 90% of testicular nonseminomatous germ cell tumors (NSGCTs).
• Retroperitoneal lymph node dissection (RPLND) is essential for accurate staging and effective treatment of NSGCTs.
• RPLND can minimize adjuvant chemotherapy needs and improve cure rates for low-volume metastases.

Purpose of the Study:

• To review the rationale and evolution of RPLND.
• To analyze the benefits and drawbacks of different surgical templates for RPLND.
• To assess the impact of nerve-sparing techniques on ejaculatory function.

Main Methods:

• Review of existing literature on RPLND techniques and outcomes.
• Comparison of bilateral RPLND with modified templates.
• Evaluation of nerve-sparing approaches in RPLND.

Main Results:

• Full bilateral RPLND maximizes cancer control and minimizes the need for further therapy.
• Modified templates, while appealing for primary RPLND, carry a 3-23% risk of residual disease.
• Limited resections after chemotherapy can lead to unacceptably high rates of residual disease.

Conclusions:

• For primary or post-chemotherapy RPLND, a full bilateral template with nerve-sparing (when indicated) offers the best oncological outcomes.
• This approach optimizes cure rates while minimizing ejaculatory dysfunction and the need for chemotherapy.
• Modified templates risk residual disease and are not recommended for all patients, especially post-chemotherapy.